Hi Rvajna,
I assume you are referring to the SP rather than the proposed treatment cost? In Hashan's article he makes a good case that NEU is potentially worth A$2-2.5b. Given our current A$1.1b MC one would say we are still very undervalued. As Jon has stated many times the key value drivers will be realised in 2023. Success with NNZ-2591 will see us exceed Hashan's valuation IMO.
If you are referring to the treatment being overpriced at potentially $150-250k; given we are yet to know what the price will be i cannot comment.
Trof Pricing - name your price, page-17
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.516B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1060 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.87 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |